ASX-listed structural heart company Anteris Technologies Ltd (ASX:AVR) is engaged in delivering clinically enhanced and durable solutions with better design and better science. The Company’s focus is to develop next-generation technologies to help healthcare specialists generate life-changing solutions for patients. The Company is developing The Anteris DurAVR™ aortic replacement valve to address the need for a superior hemodynamic profile.